换一批Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study.
第一作者：
Esther,Kissling
第一单位：
Department of Epidemiology, Epiconcept, Paris, France.;Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
作者：
Esther,Kissling [1]
;
Baltazar,Nunes [2]
;
Mariëtte,Hooiveld [3]
;
Iván,Martínez-Baz [4]
;
Susana,Monge [5]
;
Chris,Robertson [6]
;
Mirjam,Knol [7]
;
Noémie,Sève [8]
;
Ivan,Mlinarić [9]
;
Lisa,Domegan [10]
;
Ausenda,Machado [11]
;
Heather,Whitaker [12]
;
Mihaela,Lazar [13]
;
Adam,Meijer [7]
;
Theresa,Enkirch [14]
;
Itziar,Casado [4]
;
Gloria,Pérez-Gimeno [15]
;
Naoma,William [16]
;
Vincent,Enouf [17]
;
Sanja,Kurečić Filipović [9]
;
Adele,McKenna [10]
;
Ana Paula,Rodrigues [11]
;
Simon,de Lusignan [18]
;
Olivia-Carmen,Timnea [13]
;
Neus,Latorre-Margalef [14]
;
Jesús,Castilla [4]
;
Francisco,Pozo [19]
;
Mark,Hamilton [16]
;
Shirley,Masse [20]
;
Maja,Ilić [9]
;
Luca,Basile [21]
;
Joan,O'Donnell [10]
;
Raquel,Guiomar [22]
;
Maximilian,Riess [14]
;
Rodica-Manuela,Popescu [23]
;
Angela M C,Rose [2]
;
Nick,Andrews [12]
;
Sabrina,Bacci [24]
;
Lucia,Pastore Celentano [24]
;
Marta,Valenciano [2]
;
Alain,Moren [2]
;
Philippe,Beutels [25]
;
Niel,Hens [26]
;
I-MOVE-COVID-19 and ECDC primary care study teams
作者单位：
Department of Epidemiology, Epiconcept, Paris, France.;Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
[1]
Department of Epidemiology, Epiconcept, Paris, France.
[2]
Nivel, Utrecht, Netherlands.
[3]
Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.;CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
[4]
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.;National Centre for Epidemiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
[5]
Respiratory Team, Clinical and Protecting Health Directorate, Public Health Scotland, Glasgow, United Kingdom.;Department of Mathematics and Statistics, Strathclyde University, Glasgow, United Kingdom.
[6]
Centre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
[7]
Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP), F75012, Paris, France.
[8]
Division for Epidemiology of Communicable Diseases, Croatian Institute of Public Health, Zagreb, Croatia.
[9]
Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
[10]
Epidemiology Department, Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
[11]
Statistics Unit, UK Health Security Agency, London, United Kingdom.
[12]
National Influenza Centre, "Cantacuzino" National Military Medical Institute for Research and Development, Bucharest, Romania.
[13]
Department of Microbiology, The Public Health Agency of Sweden (Folkhälsomyndigheten), Stockholm, Sweden.
[14]
National Centre for Epidemiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
[15]
Respiratory Team, Clinical and Protecting Health Directorate, Public Health Scotland, Glasgow, United Kingdom.
[16]
Centre National de Référence Virus des Infections Respiratoire, M3P Unit, Institut Pasteur Université Paris Cité, Paris, France.
[17]
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.;Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom.
[18]
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.;National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
[19]
Unite des Virus Emergents (UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm 1207, IRBA), Corsica, France.
[20]
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.;Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública, Catalunya, Spain.
[21]
Reference Laboratory for Influenza and Other Respiratory Virus, Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
[22]
National Institute of Public Health, National Centre for Communicable Diseases Surveillance and Control, Bucharest, Romania.
[23]
Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control, Stockholm, Sweden.
[24]
Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
[25]
Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.;Data Science Institute, I-BioStat, Universiteit Hasselt, Hasselt, Belgium.
[26]
医学主题词
人类(Humans);病例对照研究(Case-Control Studies);时间因素(Time Factors);接种(Vaccination);研究设计(Research Design)
DOI
10.1093/aje/kwaf254
PMID
41246933
发布时间
2026-04-12
- 浏览0
American journal of epidemiology
American journal of epidemiology
1108-1119页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
